|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 555 WEST 57TH STREET |
Address2 |
|
City | NEW YORK |
State | NY |
Zip Code | 10019 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 16830-12
|
||||||||
|
6. House ID# 324950000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: David Rich |
Date | 7/19/2019 12:14:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Discuss quality and patient safety issues with CMS staff.
Discuss Medicare SNF payments with MedPAC staff.
Discuss Medicare DSH funding with CMS staff.
Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff.
Discuss NYSDOH CHSLI construction waiver with HHS staff.
Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff.
Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support).
Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts.
Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN.
Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.
Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff.
Discuss issues related to drug-resistant infections with Congressional staff.
Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff.
Educate congressional staff on Medicare for All.
Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414).
Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff.
Attend cybersecurity meeting at HHS to discuss cybersecurity in the health care sector.
Discuss CMSs FY 2020 IPPS proposed rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff and HHS.
Discuss the HHS Secretarys priorities with agency staff, specifically for Region 2, including issues related to HPV vaccinations and issues concerning the Hospital Improvement Innovation Network.
Discuss the issue of surprise medical bills with congressional staff.
Discuss New York State's Partnership for Patients initiative with CMS contract officers.
Submit formal comments letters on the Lower Health Care Costs Act (S. 1895), including the provisions related to surprise medical bills, and discussed the legislation with congressional staff.
Submit formal comments on the No Surprises Act (H.R. 3630) and discussed the legislation with congressional staff.
Discuss the Protecting People from Surprise Medical Bills Act (H.R. 3502) with congressional staff.
Discuss issues concerning DSH hospitals and hospital infrastructure needs with the Executive Branch.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office, Medicare Payment Advisory Commission (MedPAC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Substance Abuse & Mental Health Services Administration (SAMHSA), Executive Office of the President (EOP), President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lorraine |
Ryan |
|
|
|
Timothy |
Johnson |
|
|
|
Karen |
Heller |
|
|
|
Elisabeth |
Wynn |
|
|
|
Susan |
Waltman |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
|
Kenneth |
Raske |
|
|
|
Laura |
Alfredo |
|
|
|
Zeynep |
Sumer-King |
|
|
|
David |
Rich |
|
|
|
Lee |
Perlman |
|
|
|
Puja |
Khare |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414).
Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff.
Educate congressional staff on Medicare for All.
Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts.
Discuss issues concerning DSH hospitals with the Executive Branch.
Discuss CMSs FY 2020 IPPS proposed rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff and HHS.
Discuss Medicare SNF payments with MedPAC staff.
Discuss Medicare DSH funding with CMS staff.
Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff.
Oppose cuts to the 340B program.
Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff.
Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Warshaw |
|
|
|
Jonathan |
Cooper |
|
|
|
Kenneth |
Raske |
|
|
|
Timothy |
Johnson |
|
|
|
Elisabeth |
Wynn |
|
|
|
Karen |
Heller |
|
|
|
David |
Rich |
|
|
|
Lee |
Perlman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members.
Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support).
Discuss the METRIC Act (H.R. 2296) with congressional staff.
Discuss potential legislation to address drug shortages with congressional staff.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lee |
Perlman |
|
|
|
Aisling |
Zaccarelli |
|
|
|
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Oppose the hospital provisions in the White House's FY 2020 budget blueprint.
Oppose the inclusion of language that would limit HHS and its relevant subcontractors' ability to implement liver allocation reforms.
Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation.
Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kenneth |
Raske |
|
|
|
David |
Rich |
|
|
|
Jonathan |
Cooper |
|
|
|
Seth |
Warshaw |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: 555 West 57th Street
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
GNYHA Ventures, Inc. |
|
|
||||||||||||
Acurity, Inc. |
|
|
||||||||||||
GNYHA Management Corporation |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |